Doaa E. Abdel Rahman

467 total citations
17 papers, 412 citations indexed

About

Doaa E. Abdel Rahman is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Doaa E. Abdel Rahman has authored 17 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 6 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Doaa E. Abdel Rahman's work include Synthesis and biological activity (12 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Computational Drug Discovery Methods (3 papers). Doaa E. Abdel Rahman is often cited by papers focused on Synthesis and biological activity (12 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Computational Drug Discovery Methods (3 papers). Doaa E. Abdel Rahman collaborates with scholars based in Egypt, South Korea and United Kingdom. Doaa E. Abdel Rahman's co-authors include Kamelia M. Amin, Ghaneya S. Hassan, Yassin M. Nissan, M. Alaraby Salem, Heba Abdelrasheed Allam, Kamilia M. Amin, Nagwa M. Abdel Gawad, Khaled O. Mohamed, Tamer M. Abdelghany and Dalia O. Saleh and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Pharmaceutics.

In The Last Decade

Doaa E. Abdel Rahman

17 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doaa E. Abdel Rahman Egypt 10 344 102 91 59 20 17 412
Mariam A. Ghaly Egypt 12 336 1.0× 70 0.7× 110 1.2× 67 1.1× 38 1.9× 18 420
Ashish P. Keche India 11 437 1.3× 67 0.7× 199 2.2× 30 0.5× 23 1.1× 16 605
Ayla Balkan Türkiye 12 327 1.0× 121 1.2× 95 1.0× 81 1.4× 19 0.9× 32 419
O. Ozgen Türkiye 5 421 1.2× 77 0.8× 82 0.9× 55 0.9× 55 2.8× 7 506
Jalinder V. Totre India 7 344 1.0× 94 0.9× 69 0.8× 24 0.4× 24 1.2× 7 432
Keriman Ozadali‐Sari Türkiye 12 401 1.2× 143 1.4× 114 1.3× 102 1.7× 14 0.7× 22 497
Deniz S. Doğruer Türkiye 16 531 1.5× 154 1.5× 180 2.0× 113 1.9× 30 1.5× 36 663
Fa-Qian Shen China 9 246 0.7× 87 0.9× 139 1.5× 31 0.5× 39 1.9× 10 403
Mogedda E. Haiba Egypt 10 278 0.8× 41 0.4× 88 1.0× 27 0.5× 13 0.7× 22 339
Om Silakari India 11 224 0.7× 109 1.1× 188 2.1× 109 1.8× 44 2.2× 32 446

Countries citing papers authored by Doaa E. Abdel Rahman

Since Specialization
Citations

This map shows the geographic impact of Doaa E. Abdel Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doaa E. Abdel Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doaa E. Abdel Rahman more than expected).

Fields of papers citing papers by Doaa E. Abdel Rahman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doaa E. Abdel Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doaa E. Abdel Rahman. The network helps show where Doaa E. Abdel Rahman may publish in the future.

Co-authorship network of co-authors of Doaa E. Abdel Rahman

This figure shows the co-authorship network connecting the top 25 collaborators of Doaa E. Abdel Rahman. A scholar is included among the top collaborators of Doaa E. Abdel Rahman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doaa E. Abdel Rahman. Doaa E. Abdel Rahman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rahman, Doaa E. Abdel, et al.. (2023). Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation. Bioorganic Chemistry. 139. 106678–106678. 3 indexed citations
2.
Amin, Kamelia M., Doaa E. Abdel Rahman, Magda H. Abdellattif, et al.. (2022). Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties. Pharmaceutics. 14(9). 1954–1954. 5 indexed citations
3.
Amin, Kamilia M., et al.. (2021). Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease. Bioorganic Chemistry. 110. 104792–104792. 36 indexed citations
4.
Rahman, Doaa E. Abdel, et al.. (2021). Synthesis of New Hexahydropyrimido[1,2- a ]azepine Derivatives Bearing Functionalized Aryl and Heterocyclic Moieties As Anti-Inflammatory Agents. Future Medicinal Chemistry. 13(7). 625–641. 1 indexed citations
5.
Hassan, Ghaneya S., et al.. (2019). New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES. European Journal of Medicinal Chemistry. 171. 332–342. 99 indexed citations
6.
Rahman, Doaa E. Abdel, et al.. (2017). Synthesis and Anticancer Evaluation of Some New 3-Benzyl-4,8-Dimethylbenzopyrone Derivatives. PubMed. 11(1). 81–91. 5 indexed citations
7.
Hassan, Ghaneya S., et al.. (2017). Novel pyrazolopyrimidines: Synthesis, in vitro cytotoxic activity and mechanistic investigation. European Journal of Medicinal Chemistry. 138. 565–576. 22 indexed citations
8.
Hassan, Ghaneya S., et al.. (2016). DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW SUCCINIMIDE, 2-IMINOTHIAZOLINE AND OXAZINE DERIVATIVES BASED BENZOPYRONE AS ANTICONVULSANT AGENTS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(4). 222–228. 8 indexed citations
9.
Amin, Kamelia M., et al.. (2016). Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone. European Journal of Chemistry. 7(1). 19–29. 9 indexed citations
10.
Rahman, Doaa E. Abdel & Khaled O. Mohamed. (2014). Synthesis of novel 1,3,4-thiadiazole analogues with expected anticancer activity. Der pharma chemica. 6(1). 323–335. 15 indexed citations
11.
Rahman, Doaa E. Abdel, et al.. (2014). Synthesis, docking and in vitro anticancer evaluation of some new benzopyrone derivatives. Bioorganic Chemistry. 53. 50–66. 12 indexed citations
12.
Hassan, Ghaneya S., Doaa E. Abdel Rahman, Dalia O. Saleh, & Gehad A. Abdel Jaleel. (2014). Benzofuran–Morpholinomethyl–Pyrazoline Hybrids as a New Class of Vasorelaxant Agents: Synthesis and Quantitative Structure–Activity Relationship Study. Chemical and Pharmaceutical Bulletin. 62(12). 1238–1251. 11 indexed citations
15.
Hassan, Ghaneya S. & Doaa E. Abdel Rahman. (2013). Synthesis and Biological Evaluation of Some Substituted-2-<i>N</i>-(5-chloro-2-methoxy-4-methylphenylsulphonyl) Glutamic Acid Derivatives against Prostate Cancer Cell Line PC3. Chemical and Pharmaceutical Bulletin. 61(2). 212–221. 3 indexed citations
16.
Rahman, Doaa E. Abdel, et al.. (2012). Synthesis and docking studies of furobenzopyrones of potential antimicrobial and photochemotherapeutic activities. 1 indexed citations
17.
Amin, Kamelia M., et al.. (2008). Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents. Bioorganic & Medicinal Chemistry. 16(10). 5377–5388. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026